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BACKGROUND
Epithelioid glioblastoma (eGBM), is a rare, recent addition to the World Health 
Organization’s (WHO) classification of central nervous system (CNS) tumors. We 
describe a unique case of a young woman with a history of ovarian cancer 
presenting with expressive aphasia and a new left temporal brain lesion. Open 
biopsy provided a diagnosis of eGBM. Here, we discuss this unique case and a 
relevant literature review of eGBM.
Summary 
Discussion 
The epithelioid type has been added to the classification of IDH-wildtype GBM but it is 
unique in its predilection for younger patients [5] and poorer prognosis. The poor 
prognosis may be in part due to an increased propensity for leptomeningeal 
dissemination [7]. Diagnosis of eGBM relies on a combination of radiologic, histologic 
and genetic analyses. Radiologic features of eGBM include areas of cystic necrosis 
with nodular enhancement, often accompanied by vasogenic edema, mass effect and 
midline shift [4]. Genetically, eGBM differs from traditional IDH-wildtype glioblastomas 
in that it often lacks identifiers such as EGFR amplification [5]. Histologically, 
differential diagnosis includes metastatic carcinoma, metastatic melanoma and 
pleomorphic xanthoastrocytoma [1,4]. Epithelioid GBM features large epithelioid cells 
with abundant eosinophilic cytoplasm, vesicular chromatin, multiple mitotic figures, 
fairly extensive necrosis and prominent nucleoli. The appearance of the nucleoli 
particularly may cause eGBM to be mistaken for metastatic melanoma during frozen 
section analysis. Its histology may also be mistaken for pleomorphic 
xanthoastrocytomas (PXA), a WHO grade II lesion, and its anaplastic subset (PXA-A) 
with shared characteristics of loosely cohesive cells with epithelial and glial markers 
[1]. Special stains assist in narrowing the differential as GBM is typically GFAP 
positive, S-100 protein positive, negative for HBM-45 and Melan-A. 
Patient History, Examination and Imaging   
Identification and diagnosis of glioblastoma is often straightforward, however eGBM 
can radiographically mimic a metastatic lesion. Thus the importance of tissue 
sampling is paramount when differentiating from suspected cases of metastasis. As 
unique classifications of GBM are investigated it is important to further evaluate brain 
masses using histologic stains and genetic analysis for early detection of eGBM. Due 
to its poor prognosis and predilection for leptomeningeal dissemination, early 
identification of this lesion is needed for appropriate care.  Here, we discuss a 29-
year-old female with past medical history of ovarian cancer presenting with receptive 
aphasia and radiographic evidence of a temporal lesion resembling metastatic 
disease. Frozen section of this lesion suggested a metastasis. However, final 
histological evaluation of this lesion revealed eGBM, a rare and newly classified 
subtype of GBM by the WHO classification.
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Patient Outcome  
Histologic sections revealed tumor with large areas of necrosis and 
numerous mitotic figures (Figure 2A). The tumor cells consisted 
predominantly of pleomorphic epithelioid cells showing plump 
eosinophilic cytoplasm and sharp cell borders, mimicking a metastatic 
melanoma or carcinoma (Figure 2B).  The morphologic features were 
inconsistent with an ovarian juvenile-type granulosa cell tumor.  
Immunohistochemisty showed that the tumor was positive for GFAP, 
supporting glial differentiation (Figure 2C). Immunostains for 
melanoma including SOX10, HMB45 and S100 were negative. An 
immunostain for p53 also showed diffuse positivity and INI-1 showed 
no loss of nuclear expression.  Molecular analyses were also obtained 
and revealed no mutations in the IDH1 and IDH2 genes (wild-type) 
and in exon V600 of the BRAF gene. Mutations for EGFR variant III 
expression and MGMT promoter methylation were also negative.  The 
overall findings were consistent with glioblastoma, in which the 
epithelioid type was supported by the cytologic features—namely the 
sharp cell borders and rounded nuclei—that imparted a more 
epithelioid, rather than glial, appearance.  
Fig 2a,b,c: Pathological Images 
The patient's steroid taper was completed on post-operative day 7. Four weeks after 
surgery, she underwent fractionated focal irradiation targeting the previous tumor bed 
in daily fractions of 2 Gy given 5 days per week for 6 weeks. She completed an MRI 
brain with and without contrast at 3 and 6 months postoperatively which showed no 
evidence of tumor recurrence (fig 3). Patient has since refused adjuvant 
temozolamide therapy and is currently seeking nutritional therapies. She has been 
seizure-free throughout her clinical course and remains neurologically intact. 
The patient was admitted to the oncology service with frequent 
neurological evaluations and started on dexamethasone 4mg every six 
hours and levitiracetam 500mg twice daily. Five days after admission, the 
patient underwent an image-guided left frontal-temporal craniotomy. A 4cm 
incision was marked traversing superiorly from the zygoma in order to 
access the anterior inferior temporal mass. Dura was opened in a cruciate 
fashion and the tumor was located using image guidance. On gross 
examination, the lesion was firm, well encapsulated and was removed en 
bloc. Tissue from this lesion was sent for frozen section and permanent 
pathology. Frozen section suggested a poorly differentiated malignant 
metastatic lesion of unknown primary origin. After maximal safe resection, 
hemostasis was obtained, dura was closed with duraform (DePuy 
Synthesis; Raynham, MA) and the bone flap was replaced. MRI post-
operative day one suggested gross total resection.
The patient was observed overnight in the neuro-intensive care unit 
(NICU) with hourly neurologic examinations. Her pain was controlled with 
ice and Tylenol. On post-operative day one, the patient was neurologically 
intact, her foley catheter and arterial line were removed and she was 
transferred from the NICU to a general medical-surgical room.  The patient 
was monitored for an additional 24 hours, remained medically stable and 
was discharged home on post-operative day two.  She was prescribed a 
short steroid taper that would be re-evaluated on her first outpatient 
appointment seven days after surgery. 
Pathological Findings 
29-year-old female with past medical history of breast fibroadenoma and ovarian 
juvenile-type granulosa cell tumor at age fourteen presented to the emergency room 
following two episodes of disorientation, global aphasia, left-sided facial and lower 
extremity numbness with paraesthesias. The patient did not lose consciousness but 
was somnolent after both episodes. The patient states she was able to continue with 
her work that day. Further history revealed the patient had experienced intermittent 
headaches during the prior two weeks. She denied trauma, seizure history, vision 
changes, gait instability or recent illness.
Patient had a left salpingo-oophorectomy at age fourteen. Routine follow-up scans for 
five years after her cancer diagnosis suggested remission. Her last menstrual period 
was two days prior to presentation. Social history revealed the patient never smoked 
and drank socially. She denied drug use. The patient worked in communications for a 
flooring company. Patient’s mother had a known cerebral vascular abnormality and a 
maternal aunt that died of a brain aneurysm. The patient’s father was diagnosed with 
rectal cancer at age 37 and died of T-cell lymphoma at age 47. Her paternal 
grandfather had colon and lung cancer at age 47 and died at age 50. Her maternal 
grandmother was diagnosed with multiple myeloma at age 78.
Physical Examination:
Alert and oriented to self, time and place with no focal neurologic deficits
Diagnostic imaging:
MRI brain with and without contrast demonstrated an intra-axial anterior left temporal 
lobe enhancing mass measuring 1.5cm in diameter. The lesion was isointense on T1-
weighted images, hyperintense on T2-weighted images, showed ring enhancement 
on T1 with contrast and had perilesional hyperintensity on FLAIR sequence 
suggestive of vasogenic edema (Figure 1).  CT chest, abdomen and pelvis were 
remarkable for a 1.4cmx2.2cm soft tissue density within the left breast consistent with 
a benign fibroadenoma. A transvaginal ultrasound was performed which 
demonstrated a left salpingo-oophorectomy and a right ovary that measured 
4cmx2.8cmx3.7cm with slightly complex cysts that measured 2.1cmx1.5cmx2.2cm 
suggested to be a physiologic corpus luteal cyst.
Hospital Course  
Histology. A) Areas of necrosis are appreciated under low magnification H&E staining (arrows)(40x). B) Epithelioid tumor cells showing plump eosinophilic 
cytoplasm and sharp cell borders, mimicking metastatic melanoma or carcinoma (400x).  C) Tumor cells expressed GFAP by immunohistochemistry, 
supporting glial origin (400x).
Fig 3 Postoperative T1 post-contrast MRI. A) 
24-hour postoperative MRI reveals gross total 
resection with a small posterior area of residual 
enhancement consistent with postoperative 
changes.  B) 3-month and C) 6-month 
postoperative MRIs show T1 hypointensity in 
left temporal lobe without areas of residual or 
new enhancement
